StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research note published on Tuesday morning. The firm issued a hold rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
ATHX stock opened at $0.00 on Tuesday. The stock has a market capitalization of $123,438.00, a P/E ratio of 0.00 and a beta of -0.90. Athersys has a fifty-two week low of $0.01 and a fifty-two week high of $1.99.
Athersys Company Profile
Featured Articles
- Five stocks we like better than Athersys
- What Makes a Stock a Good Dividend Stock?
- Sales Breakout Sends This Semiconductor Stock to Record High
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Surprise Buying Opportunity on This Dividend Aristocrat
- Stock Dividend Cuts Happen Are You Ready?
- New Theme Park Powerhouse: Merger Creates Industry-Leading Stock
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.